| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | thalidomide | CTRPv2 | pan-cancer | AAC | -0.11 | 0.05 |
| mRNA | tacrolimus | CTRPv2 | pan-cancer | AAC | -0.069 | 0.05 |
| mRNA | Sunitinib | GDSC1000 | pan-cancer | AAC | -0.1 | 0.05 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | -0.087 | 0.06 |
| mRNA | PDMP | CTRPv2 | pan-cancer | AAC | 0.073 | 0.06 |
| mRNA | GNF-2 | GDSC1000 | pan-cancer | AAC | -0.1 | 0.06 |
| mRNA | 16-beta-bromoandrosterone | CTRPv2 | pan-cancer | AAC | 0.072 | 0.06 |
| mRNA | STF-31 | CTRPv2 | pan-cancer | AAC | 0.067 | 0.06 |
| mRNA | alvocidib | CTRPv2 | pan-cancer | AAC | 0.094 | 0.06 |
| mRNA | BRD-K09344309 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.06 |